Fake Versions Of Gilead's HIV Drugs Are In Circulation In US

  • Gilead Sciences Inc GILD warned Thursday that its original HIV treatments Biktarvy and Descovy had been replaced by fake versions at some pharmacies.
  • Unauthorized distributors could sell fake drugs to retailers, and then, "genuine Gilead bottles" were filled with counterfeit tablets, the company said.
  • Gilead has alerted potentially impacted pharmacies and is working with the FDA, pharmacies, and legal authorities to remove problematic pills from circulation and to prevent future distribution, the company added.
  • Gilead didn't disclose the number of pharmacies affected or where they are located.
  • Counterfeit medicines may not have the correct amount of active ingredients or may contain impurities. 
  • Approved by the FDA in 2018, Biktarvy quickly became the industry's best-selling HIV med and a key growth driver for Gilead. 
  • In the first half of 2021, the drug brought in $3.82 billion worldwide, roughly a 16% increase over the same period last year.
  • Descovy, combined with other drugs to treat HIV and used by itself as a PrEP option to prevent infection, brought in sales of $794 million in the first six months of 2021.
  • Price Action: GILD shares closed down 0.75% at $68.78 on Friday.
  • Photo by Mika Baumeister on Unsplash
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechNewsHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!